Dengue fever (Dengue, Breakbone Fever)

Dengue fever (Dengue, Breakbone Fever) is a disease caused by arboviruses. It is transmitted to humans mainly through the bites of Aedes aegypti mosquitoes. Symptoms last several days and include severe joint and muscle pain, headache, sore throat, fever, watery eyes and skin irritation in the form of a rash.

Usually after 2-3 days the symptoms recur, but in a weaker form. Death from this disease occurs rarely, but the patient remains weakened for a long time. Full recovery requires considerable time.

A more severe form of the disease, dengue hemorrhagic fever, is characterized by bleeding disorders and internal bleeding. It can even develop in children.

Dengue fever is most common in countries with tropical and subtropical climates. To alleviate the condition, use aspirin and codeine to reduce pain, as well as calamine lotion to relieve skin irritation.



Dengue fever (Dengue, Breakbone Fever): A disease caused by arboviruses

Dengue fever, also known as "Breakbone Fever" or "Dengue Fever", is an acute infectious disease caused by arboviruses and transmitted to humans primarily through the bite of the Aedes aegypti mosquito. It is common in tropical and subtropical regions of the world and represents a major global public health problem.

Dengue fever is characterized by a variety of symptoms that can range from mild to severe. The incubation period is usually 4 to 7 days after the bite of an infected mosquito. Early symptoms may include fever, chills, headache, eye pain, joint and muscle pain, sore throat, swollen lymph nodes, watery eyes, and skin irritation in the form of a rash similar to rubella. These symptoms may last for several days and may be accompanied by fatigue and general weakness.

Two to three days after the onset of symptoms, most patients experience relief. However, some people may develop a more severe form of the disease known as Dengue Hemorrhagic Fever (DHF). Dengue hemorrhagic fever is characterized by disorders of the blood clotting mechanism and internal bleeding. This condition can be dangerous and requires immediate medical attention. Dengue hemorrhagic fever is common in children.

Treatment for dengue fever is aimed at relieving symptoms and maintaining fluid levels in the patient's body. The main recommended medications are aspirin and codeine as they help reduce pain and reduce fever. However, it should be noted that aspirin should be taken with caution, especially in children, to avoid the risk of complications. It is also important to keep the patient hydrated by drinking enough fluids.

Dengue fever prevention and control rely on controlling and eradicating insect vectors and improving sanitation to prevent mosquito breeding. Preventative measures also include using repellents, wearing protective clothing and sleeping under mosquito nets, especially during periods when mosquitoes are most active.

It is important to see a healthcare professional if you suspect you have dengue fever, especially if you have a high fever and other typical symptoms. Seeking medical help early can help diagnose and manage the disease early, which can reduce the risk of complications.

However, the most effective means of controlling dengue fever is to prevent mosquito bites and control the mosquito population. Public education about prevention measures, regular monitoring of insect vectors, and maintaining a clean environment are important steps in preventing the spread of the disease.

Dengue fever continues to be a serious problem in many countries, especially in tropical and subtropical regions. Global efforts to control the disease, including vaccine development and improved diagnostics, are an active area of ​​research and development.

In conclusion, dengue fever, caused by arboviruses and transmitted by mosquitoes, poses a significant public health threat. Increased awareness of symptoms, preventive measures and timely seeking of medical help are important aspects of managing this disease. Care and cooperation from all stakeholders in society, including governments, health care providers and the public, is essential to successfully addressing this global threat.



Dengue fever, or cervical fever, is an acute viral disease transmitted by mosquitoes of the genus Aedes. Causes damage to the blood vessels of the body with a sharp increase in temperature to 40-41°, symptoms of general intoxication and damage to internal organs (serous membranes, blood vessels, myocardium, nervous system). The name comes from the Portuguese word dengue, which the locals of South America call traveling traders. People usually call this disease “brokin fever”.

Dengue fever affects people in more than 90 countries around the world. According to various sources, dengu carries about 30-60% of the population of mosquitoes that carry the infection. Approximately 1.2 million cases of dengue fever are reported per year in more than 70 countries, affecting a million people each year. Every year, more than 50 million people around the world become infected with the dengue virus, and up to a million of them die. Due to the uncontrolled increase in the incidence of fever in recent years, there have been reports of an increase in the incidence within countries, particularly in India